Announced Fri, 3 Jul · 18:44 IST
New Independent Director and Statutory Auditor approved, subject to shareholder vote
Management Changes View source PDF
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹88.99
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.3-2.8+0.0-2.7+1.1-2.5-5.6———
Up moveDown movePending
AI summary
Indo Us Bio-Tech board on July 3, 2026 approved seeking shareholder approval via postal ballot for: (1) regularization of Mrs. Hemanshi Darsh Soni as Non-Executive Independent Director for 5 years (originally appointed April 21, 2026), and (2) appointment of M/s. Bhagat & Associates (FRN: 101100W) as Statutory Auditor for 5 years from June 16, 2026. Mrs. Soni is not related to any director. Postal ballot voting runs July 5 to August 3, 2026.
Likely market impact
Routine governance items - new independent director and auditor seek shareholder approval. No material financial impact expected.